Mergers & Acquisitions Watch
@m-and-a-jdsupra.bsky.social
M&A news, analysis, and guidance by leading lawyers, law firms, and others in the regulatory space focused on mergers, acquisitions, and related banking/financial matters.
A JD Supra news feed
www.jdsupra.com
A JD Supra news feed
www.jdsupra.com
2025 Delaware Year in Review
2025 Delaware Year in Review
For Delaware corporate governance litigators, 2025 ended where it began. In this second installment of Season's Readings, we look back at some...
www.jdsupra.com
December 30, 2025 at 7:08 PM
2025 Delaware Year in Review
Script Scrutiny: Healthcare Non-Competes May Be a No-Go
Script Scrutiny: Healthcare Non-Competes May Be a No-Go
In recent years, state legislatures across the country have taken action to significantly reduce the scope and enforceability of non-competes in...
www.jdsupra.com
December 30, 2025 at 5:31 PM
Script Scrutiny: Healthcare Non-Competes May Be a No-Go
Five Must-Watch Antitrust Storylines for 2026
Five Must-Watch Antitrust Storylines for 2026
As an eventful 2025 in antitrust and competition comes to an end and we look forward to 2026, we reflect on the things that changed—and some...
www.jdsupra.com
December 30, 2025 at 5:40 AM
Five Must-Watch Antitrust Storylines for 2026
Navigating the New M&A Landscape: Regulatory Shifts and Deal-Ready Strategies
Navigating the New M&A Landscape: Regulatory Shifts and Deal-Ready Strategies
The M&A environment in the United States is undergoing a noteworthy transformation. While macroeconomic factors such as easing interest rates and...
www.jdsupra.com
December 29, 2025 at 9:13 PM
Navigating the New M&A Landscape: Regulatory Shifts and Deal-Ready Strategies
Healthcare & Life Sciences Private Equity Deal Tracker: Vista Equity Invests in Dentira
Healthcare & Life Sciences Private Equity Deal Tracker: Vista Equity Invests in Dentira
Vista Equity Partners has made a strategic growth investment in Dentira, according to a news release.
www.jdsupra.com
December 29, 2025 at 4:41 PM
Healthcare & Life Sciences Private Equity Deal Tracker: Vista Equity Invests in Dentira
EPR in transactions: From footnote to material liability
EPR in transactions: From footnote to material liability
Extended producer responsibility (EPR) is increasingly recognized as a core factor in transactional due diligence in the United States, with real...
www.jdsupra.com
December 27, 2025 at 2:29 AM
EPR in transactions: From footnote to material liability
Healthcare & Life Sciences Private Equity Deal Tracker: HCAP Invests in Puzzle Healthcare
Healthcare & Life Sciences Private Equity Deal Tracker: HCAP Invests in Puzzle Healthcare
HCAP Partners has announced an investment in Puzzle Healthcare.
Puzzle, founded in 2022 and based in Detroit, is a post-acute care...
www.jdsupra.com
December 26, 2025 at 6:24 PM
Healthcare & Life Sciences Private Equity Deal Tracker: HCAP Invests in Puzzle Healthcare
SEC Public Companies Enforcement: FY 2025 Review and What to Expect in 2026
SEC Public Companies Enforcement: FY 2025 Review and What to Expect in 2026
When Paul Atkins became the new chairman of the Securities and Exchange Commission (SEC) in April 2025, the market expected enforcement actions...
www.jdsupra.com
December 26, 2025 at 5:51 PM
SEC Public Companies Enforcement: FY 2025 Review and What to Expect in 2026
Dealmaker's Digest: A Top 10 Bulletin - December 2025
Dealmaker's Digest: A Top 10 Bulletin - December 2025
In Dealmaker’s Digest, read the top 10 latest developments in global transactions. We offer insights into M&A activity across industries and...
www.jdsupra.com
December 26, 2025 at 5:50 PM
Dealmaker's Digest: A Top 10 Bulletin - December 2025
China Monthly Antitrust Update - December 2025
China Monthly Antitrust Update - December 2025
This monthly report outlines key developments in China’s antitrust sector for December. The following events merit special attention: On 15...
www.jdsupra.com
December 26, 2025 at 5:45 PM
China Monthly Antitrust Update - December 2025
Making the Most of JPM: A Readiness Guide for Life Sciences Companies
Making the Most of JPM: A Readiness Guide for Life Sciences Companies
The J.P. Morgan Healthcare Conference is the most important week of the year for life sciences companies, investors and dealmakers. With more...
www.jdsupra.com
December 26, 2025 at 5:22 PM
Making the Most of JPM: A Readiness Guide for Life Sciences Companies
Energy And Entertainment Mergers Now Take Center Stage
Energy And Entertainment Mergers Now Take Center Stage
On December 7, 2025, Constellation Energy settled a lawsuit previously filed against it by the United States Department of Justice and the State...
www.jdsupra.com
December 26, 2025 at 2:22 PM
Energy And Entertainment Mergers Now Take Center Stage
The Rush to Exit: PE Firms Pick Up the Pace in 2025
The Rush to Exit: PE Firms Pick Up the Pace in 2025
PE firms are moving to sell portfolio companies on an accelerated timeline in 2025 after years of much longer hold cycles.
PitchBook data...
www.jdsupra.com
December 26, 2025 at 2:21 PM
The Rush to Exit: PE Firms Pick Up the Pace in 2025
Buyer Beware - New Restrictions on the Purchase and Sale of Medical Equipment Companies
Buyer Beware - New Restrictions on the Purchase and Sale of Medical Equipment Companies
Durable Medical Equipment (DME) owners and prospective purchasers need to be aware of a new Medicare rule that significantly restricts the...
www.jdsupra.com
December 24, 2025 at 5:31 AM
Buyer Beware - New Restrictions on the Purchase and Sale of Medical Equipment Companies
Australian Leveraged Finance in 2025: Market Trends, Structures And Term
Australian Leveraged Finance in 2025: Market Trends, Structures And Term
Australia's leveraged finance market is ending the year well-positioned to support a hopeful M&A comeback in 2026. Deep Australian/Asia-Pacific...
www.jdsupra.com
December 23, 2025 at 7:54 PM
Australian Leveraged Finance in 2025: Market Trends, Structures And Term
What is a Disclosure Schedule, and Why Do I Need to Prepare One?
What is a Disclosure Schedule, and Why Do I Need to Prepare One?
When a company receives a venture investment, or is acquired, it typically must prepare a “disclosure schedule” (also sometimes called a...
www.jdsupra.com
December 23, 2025 at 7:10 PM
What is a Disclosure Schedule, and Why Do I Need to Prepare One?
The Appellate Court of Maryland Reaffirms Business Judgment Protections for Directors of a Maryland Corporation in Rejecting an Unsolicited Topping Bid
The Appellate Court of Maryland Reaffirms Business Judgment Protections for Directors of a Maryland Corporation in Rejecting an Unsolicited Topping Bid
In a sweeping ruling, the Appellate Court of Maryland, our intermediate appellate court, rejected the appellant-stockholders' claims that the...
www.jdsupra.com
December 23, 2025 at 6:54 PM
The Appellate Court of Maryland Reaffirms Business Judgment Protections for Directors of a Maryland Corporation in Rejecting an Unsolicited Topping Bid
Recent California Laws Increase Scrutiny on Investments in Healthcare Businesses
Recent California Laws Increase Scrutiny on Investments in Healthcare Businesses
In October, California Governor Gavin Newsom signed into law two bills that create additional hurdles for investors in healthcare businesses. AB...
www.jdsupra.com
December 23, 2025 at 5:31 PM
Recent California Laws Increase Scrutiny on Investments in Healthcare Businesses
Glow and Grow: What's Shaping M&A in the Beauty Industry
Glow and Grow: What's Shaping M&A in the Beauty Industry
Newly released market data out of the US shows the demand for beauty products remained strong in 2025 despite pressure on overall consumer...
www.jdsupra.com
December 23, 2025 at 4:09 PM
Glow and Grow: What's Shaping M&A in the Beauty Industry
EBA Consultation On RTS And ITS Under CRD IV On Material Acquisitions, Transfers, Mergers And Divisions
EBA Consultation On RTS And ITS Under CRD IV On Material Acquisitions, Transfers, Mergers And Divisions
The European Banking Authority (EBA) has launched a consultation on draft regulatory technical standards (RTS) and implementing technical...
www.jdsupra.com
December 23, 2025 at 2:58 PM
EBA Consultation On RTS And ITS Under CRD IV On Material Acquisitions, Transfers, Mergers And Divisions
Avantage concurrentiel par Blakes : mise à jour de décembre 2025
Avantage concurrentiel par Blakes : mise à jour de décembre 2025
Bienvenue à l’édition de décembre de l’infolettre Avantage concurrentiel par Blakes, une publication mensuelle des groupes Concurrence et...
www.jdsupra.com
December 22, 2025 at 7:35 PM
Avantage concurrentiel par Blakes : mise à jour de décembre 2025
Where healthcare exits are heading in 2026
Where healthcare exits are heading in 2026
As we look to 2026, exits aren’t just about timing. Dealmakers are utilizing process, planning, and creativity to find new paths to liquidity....
www.jdsupra.com
December 22, 2025 at 6:32 PM
Where healthcare exits are heading in 2026
Market analysis: 10 trends affecting global private markets for 2026
Market analysis: 10 trends affecting global private markets for 2026
Welcome to the fifth edition of the Private Markets Update, a report in which our cross-border, multidisciplinary team of private capital...
www.jdsupra.com
December 22, 2025 at 6:29 PM
Market analysis: 10 trends affecting global private markets for 2026
The trends shaping cross-border M&A in 2026
The trends shaping cross-border M&A in 2026
Megatrends around international trade flows, energy transition, technology, and critical minerals that are driving M&A strategies are...
www.jdsupra.com
December 22, 2025 at 6:28 PM
The trends shaping cross-border M&A in 2026
Setting the private capital compass for 2026
Setting the private capital compass for 2026
Private capital strategies are evolving around a more unified, solutions-driven toolkit. Dealmaking saw a rebound and private market expansion...
www.jdsupra.com
December 22, 2025 at 6:19 PM
Setting the private capital compass for 2026